Description

1H-as-Indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-O-methyl-.alpha.-L-mannopyranosyl)oxy-13-(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yloxy-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-9,14-dimethyl-, (2R,3aS,5a is a complex, high-purity organic compound characterized by its intricate polycyclic structure with multiple chiral centers and functional groups. This compound is of significant interest for advanced research and development due to its potential as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories, biotechnology firms, and academic research institutions engaged in medicinal chemistry and drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of complex drug candidates, particularly in oncology and anti-infective research.
• Medicinal Chemistry Research: Used as a reference standard or a starting material for structure-activity relationship (SAR) studies to optimize biological activity.
• Biochemical Research: Potential application in studying enzyme inhibition or receptor binding mechanisms due to its specific stereochemistry and functional groups.
• Process Development: Employed in scaling up synthetic routes from laboratory to pilot plant scale for potential commercial drug manufacturing.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and development of Active Pharmaceutical Ingredients (APIs).

Basic Information

Item	Details
Product Name	1H-as-Indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-O-methyl-.alpha.-L-mannopyranosyl)oxy-13-(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yloxy-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-9,14-dimethyl-, (2R,3aS,5a
CAS No.	131929-64-1
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	131929-64-1; (2R,3aS,5aR,5bS,9S,13R,14R,16aS,16bR)-13-(((2R,5S,6R)-5-(Dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-9,14-dimethyl-2-(((2R,3R,4R,5R,6S)-3,4,5-trimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,3,3a,4,5,5a,5b,6,7,8,9,10,11,12,13,14,16a,16b-octadecahydro-1H-as-indaceno[3,2-d]oxacyclododecine-7,15-dione; Complex Indacenodioxacyclododecine Derivative; Advanced Pharmaceutical Intermediate 131929-64-1
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards for research and pharmaceutical intermediates. We adhere to strict in-house specifications that typically include identity confirmation, purity assessment, and impurity profiling. Certificates of Analysis (COA) detailing batch-specific results from analytical techniques such as HPLC, NMR, and MS are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.